tiprankstipranks
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
Holding AVDL?
Track your performance easily

Avadel Pharmaceuticals (AVDL) Financial Statements

671 Followers

Avadel Pharmaceuticals Financial Overview

Avadel Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.772; its P/E ratio is -13.92; Avadel Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 41.50M$ 27.18M$ 19.45M$ 7.01M$ 1.50M
Gross Profit$ 38.72M$ 25.66M$ 18.76M$ 6.90M$ 1.46M
EBIT$ -11.62M$ -24.66M$ -26.53M$ -34.21M$ -62.05M
EBITDA$ -11.18M$ -24.12M$ -26.53M$ -33.61M$ -60.86M
Net Income Common Stockholders$ -13.82M$ -27.34M$ -28.79M$ -36.27M$ -64.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 71.38M$ 88.79M$ 105.11M$ 153.18M$ 160.51M
Total Assets$ 157.52M$ 167.90M$ 164.70M$ 203.10M$ 200.98M
Total Debt$ 2.17M$ 2.40M$ 2.62M$ 24.03M$ 22.12M
Net Debt$ -69.21M$ -86.39M$ -102.49M$ -129.15M$ -138.39M
Total Liabilities$ 87.23M$ 89.52M$ 76.96M$ 92.95M$ 57.78M
Stockholders Equity$ 70.29M$ 78.38M$ 87.74M$ 110.15M$ 143.19M
Cash Flow-
Free Cash Flow$ -18.19M$ -29.70M$ -28.03M$ -38.23M$ -32.02M
Operating Cash Flow$ -18.19M$ -29.70M$ -28.03M$ -38.23M$ -32.02M
Investing Cash Flow$ 10.55M$ 21.39M$ 27.93M$ 9.82M$ -92.91M
Financing Cash Flow$ 723.00K$ 13.19M$ -21.11M$ 30.46M$ 91.54M
Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

Avadel Pharmaceuticals Debt to Assets

Avadel Pharmaceuticals Cash Flow

Avadel Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis